Skip to main content
Clinical Trials/NCT01696916
NCT01696916CompletedNot Applicable

Development of the Partial Pressure of Carbon Dioxide During 6-min Walking Test and at Night in Patients With Chronic Obstructive Pulmonary Disease IV

Schön Klinik Berchtesgadener Land1 site in 1 country75 target enrollmentStarted: March 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Locations
1
Primary Endpoint
Increase of PaCO2 more than 5mmHg

Study Overview

Brief Summary

The aim of this study is to investigate the development of partial pressure of carbon dioxide during the 6-min walking test and during night in Chronic Obstructive Pulmonary Disease (COPD)-patients (GOLD stage IV). Therefore the partial pressure of carbon dioxide, oxygen saturation and the heart rate are registered by a device called "Sentec" during the mentioned periods. In addition a measurement of activity is realised by an activity monitor ("Sensewear").

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
30 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •COPD IV with and without a respiratory insufficiency
  • •maximal paCO² of 55mmHg at admission (taken at rest by blood gas analysis without LTOT)

Exclusion Criteria

  • •paCO² > 55mmHg
  • •non-invasive ventilation
  • •acute exacerbation

Arms & Interventions

exercise testing

Experimental

6-minute walking test with pCO2 and pO2 measurement

Intervention: 6-minute walking test (Procedure)

Outcomes

Primary Outcomes

Increase of PaCO2 more than 5mmHg

Time Frame: From time of starting 6-minute walking test until the time of PaCO2-increase of more than 5mmHg assessed up to 6 minutes.

Secondary Outcomes

  • Change of PaCO2(From the beginning of the 6-minute walking test until peak PaCO2, assessed up to 6 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Klaus Kenn

Head physician (department of pneumology)

Schön Klinik Berchtesgadener Land

Study Sites (1)

Loading locations...

Similar Trials